Okava Ltd secures funding for companion animal health technology

Pet longevity is the primary focus of Okava Ltd, a Cambridge-based firm that develops veterinary-medicine products for dogs and cats. Founded in 2022, the company provides solutions for owners who want to extend the lives of their companion animals through specialized medical offerings and technologies. It functions as a technology-driven service provider to deliver these health-focused tools to the consumer market in the United Kingdom.

A recent funding round has added an estimated £10k to the company's balance sheet. This capital injection follows a larger period of fundraising activity, with the business having secured a total of £1m during the current 2026 calendar year.

According to the most recent accounts for the period ending 31 January 2025, the startup operates with a team of four employees. The administrative process for this latest share issue concluded recently at Companies House (with a formal filing in September and an initial allotment of shares in August).